Frankfurt
15.07.26 | 09:13
3,040 Euro
-1,30 % -0,040
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 3,000 | 3,220 | 09:38 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06.07. | Nephros added to Russell Microcap Index | 2 | Investing.com | ||
| 18.06. | Nephros, Inc.: Nephros to Host Virtual Investor Event: "Beyond Filtration: The Nephros Model in Action" | 3 | GlobeNewswire (USA) | ||
| 16.06. | Nephros highlights filtration technology for microplastics removal | 1 | Investing.com | ||
| 16.06. | Nephros, Inc.: Nephros Positions Ultrafiltration Technology as a Solution to Emerging Microplastic Risk in Water | 1 | GlobeNewswire (USA) | ||
| 12.06. | NEPHROS INC - 8-K, Current Report | - | SEC Filings | ||
| 08.05. | Nephros expects tariff relief from 10% rate to support margins later in 2026 | 1 | Seeking Alpha | ||
| 07.05. | NEPHROS INC - 8-K, Current Report | - | SEC Filings | ||
| 16.04. | Nephros, Inc.: Nephros Expands Strategic Focus in Greater New York Market with Dedicated Regional Leadership | 2 | GlobeNewswire (USA) | ||
| NEPHROS Aktie jetzt für 0€ handeln | |||||
| 01.04. | Nephros, Inc.: Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise | 1 | GlobeNewswire (USA) | ||
| 01.04. | Trotz Gewinnüberraschung: Nephros-Aktie fällt nach Q4-Zahlen | 2 | Investing.com Deutsch | ||
| 27.03. | NEPHROS INC - 8-K, Current Report | 1 | SEC Filings | ||
| 18.03. | Benchmark reiterates Nephros stock Speculative Buy on Q4 beat | 1 | Investing.com | ||
| 12.03. | Trotz starker Zahlen: Nephros-Aktie gibt nach Quartalsbericht nach | 1 | Investing.com Deutsch | ||
| 12.03. | Nephros, Inc.: Nephros Announces Fourth Quarter and Record Fiscal Year 2025 Financial Results | 782 | GlobeNewswire (Europe) | Full-Year Net Revenue Increased 33% Y-O-Y to $18.8 Million and Fourth-Quarter Net Revenue up 22% Y-O-Y to $4.7 Million Reports Second Consecutive Year of Positive Net Income SOUTH ORANGE, N.J., March... ► Artikel lesen | |
| 12.03. | NEPHROS INC - 10-K, Annual Report | 1 | SEC Filings | ||
| 13.02. | Nephros expands into Puerto Rico with water filtration solutions | 1 | Investing.com | ||
| 13.02. | Nephros expandiert mit Wasserfilterlösungen nach Puerto Rico | 1 | Investing.com Deutsch | ||
| 13.02. | Nephros, Inc.: Nephros Expands into Puerto Rico to Deliver Differentiated Water Filtration Solutions Across Medical and Commercial Sectors | 1 | GlobeNewswire (USA) |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 69,68 | +0,01 % | Raymond James initiates BrightSpring Health stock with outperform rating | ||
| BILLIONTOONE | 124,59 | -0,22 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,210 | +0,05 % | Kaplan Fox & Kilsheimer LLP: Kaplan Fox Alerts Investors of Alignment Healthcare, Inc. (ALHC) to an Investigation of Potential Securities Law Violations | New York, New York--(Newsfile Corp. - July 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or... ► Artikel lesen | |
| BETA BIONICS | 16,860 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| GENEDX | 62,37 | -0,10 % | Piper Sandler raises GeneDx stock price target on coverage policy | ||
| HEARTFLOW | 25,500 | +0,04 % | Heartflow, Inc.: New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management | ||
| ADAPTHEALTH | 10,190 | 0,00 % | AdaptHealth Flags Material Breach After Threat Actor Accessed Patient Management Systems | ||
| PROCEPT BIOROBOTICS | 19,300 | -0,05 % | PROCEPT BioRobotics to Report Second Quarter 2026 Financial Results on August 4th, 2026 | ||
| PROGYNY | 32,360 | 0,00 % | KeyBanc raises Progyny stock price target on utilization strength | ||
| LIFESTANCE HEALTH GROUP | 10,795 | +0,05 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 28,030 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 9,350 | +0,11 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Completes Acquisition of Family First Homecare and Updates Full Year 2026 Guidance | ATLANTA, June 02, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen | |
| ONCOLOGY INSTITUTE | 6,290 | +0,16 % | BTIG hebt Kursziel für Oncology Institute Aktie nach Umschuldung auf 9 US-Dollar an | ||
| CLEARPOINT NEURO | 15,960 | 0,00 % | EpilepsyGTx Taps ClearPoint Neuro for EPY201 Clinical Trial Delivery | ||
| PACS GROUP | 44,920 | 0,00 % | Hohes Handelsaufkommen bei Optionen der Pacs Group |
Das Unternehmen NEPHROS INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 3,040 Euro und damit -1,30 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEPHROS INC finden Sie auf Wallstreet Online.